Sort
48,018 grants matching “immunotherapy”
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
$448,416Cristian T Badea · Duke University · U24 · FY2020 · CA
eRapa for bladder cancer prevention
$448,412Robert Scott Svatek · University Of Texas Hlth Science Center · R01 · FY2022 · CA
Immunobiology of Myeloid and Lymphoid Cells
$448,397Edward John Usherwood · Dartmouth College · T32 · FY2021 · AI
Non-invasive Quantification of Dose-Exposure-Response of PD-L1 Therapeutics at the Tumor
$448,389Sridhar Nimmagadda · Johns Hopkins University · R01 · FY2022 · CA
Transport Oncophysics Core
$448,357Haifa Shen · Methodist Hospital Research Institute · U54 · FY2018 · CA
TOLERANCE OF ISLET CELL GRAFT
$448,306University Of California San Francisco · R01 · FY2000 · DK
Pathogenesis and treatment of sporadic Inclusion Body Myositis in mouse models.
$448,277Thomas E. Lloyd · Johns Hopkins University · R01 · FY2021 · AR
Pathogenesis and treatment of sporadic Inclusion Body Myositis in mouse models.
$448,276Philip C Wong · Johns Hopkins University · R01 · FY2024 · AR
Epigenetic Therapy for Thoracic Malignanceis
$448,245David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
$448,226Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers
$448,200Catherine C Hedrick · La Jolla Institute For Immunology · U01 · FY2020 · CA
Development of a Theranostic Immunotherapy for Systemic Amyloidosis
$448,172Jonathan S Wall · University Of Tennessee Health Sci Ctr · R01 · FY2023 · DK
Modulation of repopulation of anti HIV-1 gene-modified cells to enhance efficacy and safety
$448,040Dong Sung An · University Of California Los Angeles · U19 · FY2022 · AI
The adaptive immune response to food antigens in the gut
$448,000Stephanie Caroline Eisenbarth · Yale University · R56 · FY2021 · AI
NanoOptogenetic immunotherapy for B cell lymphoma
$447,986Gang Han · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · CA
Roswell Park Cancer Institute Cancer Center Support Grant
$447,972Candace S Johnson · Roswell Park Cancer Institute Corp · P30 · FY2016 · CA
Two Compartment Models to Improve Brain Tumor Therapy
$447,921Edward A Neuwelt · Oregon Health & Science University · R01 · FY2017 · CA
T cell costimulation and regulation in myocarditis
$447,920Brigham And Women'S Hospital · R01 · FY2005 · HL
From the Past to the Future: Chimeric Antigen Receptor T cells for Lymphoid Malignancies
$447,870Joseph Anthony Fraietta · University Of Pennsylvania · P01 · FY2024 · CA
Development of Chimeric Antigen Receptor Phagocytes Against Glioblastoma
$447,831Siddhartha S. Mitra · University Of Colorado Denver · R01 · FY2024 · CA
Core B: Biostatistics and Bioinformatics
$447,800Ted Gooley · Fred Hutchinson Cancer Research Center · P01 · FY2020 · CA
Chimeric Anti CD20 T Cell Receptors for Lymphoma Therapy
$447,750Fred Hutchinson Cancer Research Center · R01 · FY2003 · CA
Early Detection of Cerebral Amyloid Angiopathy
$447,684Steven M Greenberg · Massachusetts General Hospital · R01 · FY2013 · NS
B. anthracis:passive immunization with anticapsular mAb
$447,683University Of Nevada Reno · R01 · FY2005 · AI
Brain tumors with regulatory T-cells treated with EGFRvIII-specific T-cells
$447,602John H Sampson · Duke University · R01 · FY2017 · CA